One-Year Prediction of Vision-Threatening Diabetic Retinopathy Complications Using Multimodal Artificial Intelligence: A Multicenter Real-World Study
Current diabetic retinopathy management relies primarily on contemporaneous severity grading and does not directly quantify the short-term risk of vision-threatening complications. We developed and internally evaluated image-based artificial intelligence models for one-year prediction of diabetic retinopathy severity, proliferative diabetic retinopathy (PDR) and center-involved diabetic macular edema (ci-DME) using retinal imaging acquired during routine care.The prospective multicenter EviRed cohort included 3,183 patients with diabetes, 8,520 visits and 16,509 eye-level observations collected across 14 French hospitals. Device-specific ensembles were developed for ultra-widefield color fundus photography (CLARUS500 and OPTOS) and OCT angiography (CIRRUS5000 and PLEX Elite9000). Predictions from individual images and both eyes were aggregated at the patient-visit level. Participants were partitioned at the patient level into adevelopment set (65\%) and a held-out test set (35\%).For prediction of diabetic retinopathy severity at the subsequent annual visit, OPTOS and CLARUS500 achieved quadratic weighted kappa values of 0.866 (95\% confidence interval, 0.842--0.878) and 0.852 (0.830--0.877), respectively. For incident ci-DME, CIRRUS5000 achieved the highest discrimination (AUC, 0.826; 0.770--0.878), whereas PLEX Elite9000 yielded the highest AUC point estimate for incident PDR (0.877; 0.807--0.950). Late fusion did not consistently outperform the strongest device-specific model. In secondary complete-case analyses, observed ci-DME incidence increased across quartiles of the image-derived risk score, reaching 19.7--30.4\% in the highest-risk quartile. AI models also achieved higher AUC point estimates than unassisted expert risk assessments for both complications, although these comparisons were exploratory.Retinal imaging acquired at a single routine-care visit therefore contains information associated with diabetic retinopathy severity and vision-threatening complications one year later. These findings support image-based short-term risk stratification, while external validation, calibration and prospective clinical utility assessment remain necessary before deployment.
Authors
- Abir Zureik (ORCID: https://orcid.org/0000-0002-4236-6196)
- Mohsen Tabejamaat (ORCID: https://orcid.org/0000-0002-8815-5730)
- Gwenolé Quellec (ORCID: https://orcid.org/0000-0003-1669-7140)
- Mathias Gallardo (ORCID: https://orcid.org/0000-0002-6616-3895)
- Pascale Massin (ORCID: https://orcid.org/0000-0003-1182-0736)
- Deborah Cosette
- Philippe Zhang (ORCID: https://orcid.org/0009-0007-9931-1990)
- Aurélien Ducournau
- Mathieu Lamard (ORCID: https://orcid.org/0000-0002-6309-6156)
- Alireza Rezaei (ORCID: https://orcid.org/0000-0001-5067-2030)
- Francois Potevin
- Pierre Deman
- Laurent Borderie (ORCID: https://orcid.org/0009-0007-0044-3409)
- Sejal Ghate
- Éric Vicaut (ORCID: https://orcid.org/0000-0001-6303-8557)
- Aude Couturier (ORCID: https://orcid.org/0000-0001-8549-7455)
- Capucine Lepicard
- Marine De Bony
- Ali Salehi (ORCID: https://orcid.org/0009-0006-9991-724X)
- Hugo LE BOITE
- Alexandre LE GUILCHER
- Mostafa EL HABIB DAHO
- EviRed Investigators
Institutions
- Carl Zeiss (Germany) (DE)
- Université de Bretagne Occidentale (FR)
- Université Paris Cité (FR)
- Hôpital Lariboisière (FR)
- Laboratoire de Traitement de l'Information Médicale (FR)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-18
- DOI
- https://doi.org/10.21203/rs.3.rs-11433556/v1
- Primary Topic
- Retinal Imaging and Analysis
- Type
- preprint
Funders
- Agence Nationale de la Recherche